Inventor · disambiguated record
Rupa Shetty
Also filed as: SHETTY RUPA · SHETTY RUPA S
21 granted patents·5 pending applications·103 citations·filing 1998–2023
94Inventor score
Files withPRELUDE THERAPEUTICS INC18RES TRIANGLE INST5LOCUS PHARMACEUTICALS INC1RES TRIANGLE RESEARCH NORTH CA1SHETTY RUPA S1
Top patents by PatentIndex Score
26 records- 0194US11254683B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Feb 22, 2022·3 cites·35 claims
- 0294US11214574B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Jan 4, 2022·3 cites·16 claims
- 0392US11673893B2CDK inhibitors and their use as pharmaceuticalsPRELUDE THERAPEUTICS INC·Filed 2020·Granted Jun 13, 2023·4 cites·10 claims
- 0491US10570140B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2018·Granted Feb 25, 2020·4 cites·29 claims
- 0590US10711007B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2019·Granted Jul 14, 2020·6 cites·26 claims
- 0685US11208416B2Selective inhibitors of protein arginine methytransterase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Dec 28, 2021·1 cites·37 claims
- 0773US2022153747A1Selective Inhibitors Of Protein Arginine Methytransterase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0872US12459950B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2022·Granted Nov 4, 2025·0 cites·20 claims
- 0972US6620801B217β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal propertiesRES TRIANGLE INST·Filed 2001·Granted Sep 16, 2003·5 cites·10 claims
- 1071US12486277B2CDK inhibitors and their use as pharmaceuticalsPRELUDE THERAPEUTICS INC·Filed 2023·Granted Dec 2, 2025·0 cites·23 claims
- 1169US11078205B2Selective inhibitors of protein arginine methlytransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Aug 3, 2021·0 cites·26 claims
- 1269US7018991B217β-amino and hydroxylamino-11 β-arylsteroids and their derivatives having agonist or antagonist hormonal propertiesRES TRIANGLE INST·Filed 2003·Granted Mar 28, 2006·3 cites·18 claims
- 1366US8962623B2Aminopyrazine compoundsSHETTY RUPA S·Filed 2012·Granted Feb 24, 2015·4 cites·13 claims
- 1466US5962444A17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal propertiesRES TRIANGLE INST·Filed 1998·Granted Oct 5, 1999·19 cites·9 claims
- 1564US2023010358A1Spiro-Sulfonamide Derivatives As Inhibitors Of Myeloid Cell Leukemia-1 (MCL-1) ProteinPRELUDE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1663US11130769B2Spiro-sulfonamide derivatives as inhibitors of myeloid cell leukemia-1 (MCL-1) proteinPRELUDE THERAPEUTICS INC·Filed 2019·Granted Sep 28, 2021·0 cites·31 claims
- 1763US6043235A11β-aryl-17, 17-spirothiolane-substituted steroidsRES TRIANGLE INST·Filed 1999·Granted Mar 28, 2000·21 cites·10 claims
- 1862US6015805A17β-nitro-11β-arylisteroids and their derivatives having agonist or antagonist hormonal propertiesRES TRIANGLE RESEARCH NORTH CA·Filed 1999·Granted Jan 18, 2000·18 cites·12 claims
- 1959US6093707A17β-nitro-11β-arylsteroids and their derivatives having agonist or antagonist hormonal propertiesRES TRIANGLE INST·Filed 1999·Granted Jul 25, 2000·12 cites·10 claims
- 2057US2023144528A1CDK Inhibitors And Their Use As PharmaceuticalsPRELUDE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2151US12448389B2BRM targeting compounds and associated methods of usePRELUDE THERAPEUTICS INC·Filed 2021·Granted Oct 21, 2025·0 cites·29 claims
- 2249US2022218732A1Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2348US2022152072A1Selective Inhibitors Of Protein Arginine Methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2446US12440506B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2020·Granted Oct 14, 2025·0 cites·50 claims
- 2543US11220524B2Selective inhibitors of protein arginine methyltransferase 5 (PRMT5)PRELUDE THERAPEUTICS INC·Filed 2018·Granted Jan 11, 2022·0 cites·20 claims
- 2638US7741479B2Urea inhibitors of MAP kinasesLOCUS PHARMACEUTICALS INC·Filed 2005·Granted Jun 22, 2010·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Rupa Shetty files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →